Boswellia 250 mg

by Bronson · capsule · 120 capsules

  • On the market (NIH)
  • UPC 7 16563 44402 0
  • DSLD label 257382
  • Serving 1 capsule
  • 120 servings

Boswellia 250 mg by Bronson lists one ingredient: 250 mg of boswellia extract per serving of 1 capsule. Its current label entered the NIH Dietary Supplement Label Database on December 18, 2021.

What is in Boswellia 250 mg?

Each row as the label prints it, per serving of 1 capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Boswellia 250 mg: Supplement Facts rows against the market (DSLD label 257382, January 2026 release)
IngredientAmount% DVAmong products listing it
Boswellia extractas Boswellic Acids250 mgBoswellia in Boswellia 250 mg against 665 products250 mg per serving; the middle half of products list 100 mg to 290 mg, the median 135 mg.250 mg

Higher than 69% of 665 products listing boswellia (median 135 mg). Per day at the most servings: 500 mg.

Source: NIH ODS Dietary Supplement Label Database, label 257382 (entered December 18, 2021), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records 2 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Directions: As a dietary supplement for adults, 1 capsule two times daily, preferably with meals or as directed by a health professional.
Warnings
Warning: If you are pregnant, nursing, or taking medications, consult your health professional before use.
Discontinue use and consult your healthcare professional if adverse reactions occur.
Do not use if seal under cap is broken or missing.
Keep out of reach of children.
Storage
Store at room temperature.

Source: label statements in DSLD label 257382.

What else is on the label?

Other ingredients: Microcrystalline Cellulose, Gelatin Capsule, Magnesium Stearate.

Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): Lab tested Made from high quality ingredients 365 days 100% money back guaranteed; GMP good manufacturing practice.

How many labels does Boswellia 250 mg have?

One label is on file, entered on December 18, 2021.

  1. Label 257382 (current) Entered December 18, 2021 · on the market · 120 capsules · UPC 7 16563 44402 0

DSLD also links this label to: Boswellia 250 mg (image difference, same product).

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Bronson Laboratories (manufacturer), Lindon, UT. All Bronson products.

Where next?